Paper1259639
Editorial: The prevalence and malignancy of Alzheimer disease. A major killer.
Katzman R. Arch Neurol, 1976. Cited by 540 papers, by iCite.
Cite this record
ConductScience Library. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Papers, record 1259639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1259639
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Dementia | Major topic |
| Humans | |
| United States |
Source PubMed
Cited by124
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 540 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42921272 | Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42921272 | PubMed |
| 42805939 | Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42805939 | PubMed |
| 42274769 | Alzheimer's disease-cancer research (inception to 2025): trends, themes, translational pathways, and insights from highly cited studies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42274769 | PubMed |
| 42186792 | Behavior of neural networks in culture suggest that sporadic and genetic forms of Alzheimer's disease may not be equivalent. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42186792 | PubMed |
| 41702711 | Defining Alzheimer's disease: stipulations and the ethics of diagnostic change. | J Neurol Neurosurg Psychiatry | 2026 | https://conductscience.org/library/papers/41702711 | PubMed |
| 41227148 | Alzheimer Syndrome or Age-Related Dementia-History, Therapy and Prevention. | J Clin Med | 2025 | https://conductscience.org/library/papers/41227148 | PubMed |
| 41200107 | Developing and optimizing a biocompatible tauopathy model using extracellular vesicle-mediated gene delivery. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41200107 | PubMed |
| 41085158 | Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41085158 | PubMed |
| 41056420 | Placing public health onto the Alzheimer's disease and related dementias public policy platform. | Gerontologist | 2025 | https://conductscience.org/library/papers/41056420 | PubMed |
| 40864225 | Donepezil and Memantine Derivatives for Dual-Function and Prodrug Applications in Alzheimer's Disease. | ACS Chem Neurosci | 2025 | https://conductscience.org/library/papers/40864225 | PubMed |
| 40772536 | The first 25 years of the Northwestern University SuperAging Program. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40772536 | PubMed |
| 40011173 | Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics. | J Prev Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40011173 | PubMed |
| 39529357 | Alzheimer's disease: part 2 - the present. | Arq Neuropsiquiatr | 2024 | https://conductscience.org/library/papers/39529357 | PubMed |
| 39473810 | Characteristics of Alzheimer's Disease and Mild Cognitive Impairment Influenced by the Time of Onset. | Dement Geriatr Cogn Dis Extra | 2024 | https://conductscience.org/library/papers/39473810 | PubMed |
| 39295642 | In 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/39295642 | PubMed |
| 38863570 | What is "biological Alzheimer's disease"? | Dement Neuropsychol | 2024 | https://conductscience.org/library/papers/38863570 | PubMed |
| 38641654 | The advent of Alzheimer treatments will change the trajectory of human aging. | Nat Aging | 2024 | https://conductscience.org/library/papers/38641654 | PubMed |
| 38618742 | What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries. | Eur J Neurol | 2024 | https://conductscience.org/library/papers/38618742 | PubMed |
| 38482142 | Atypical clinical variants of Alzheimer's disease: are they really atypical? | Front Neurosci | 2024 | https://conductscience.org/library/papers/38482142 | PubMed |
| 38256670 | Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History. | J Clin Med | 2024 | https://conductscience.org/library/papers/38256670 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1259639
GET https://conductscience.org/api/papers/v1/1259639/cited_by?page=2